According to our (Global Info Research) latest study, the global Non-invasive Intracranial Pressure Monitoring Device market size was valued at US$ 124 million in 2025 and is forecast to a readjusted size of US$ 187 million by 2032 with a CAGR of 6.0% during review period.
A non-invasive intracranial pressure (ICP) monitoring device refers to a system that assesses intracranial pressure dynamics without skull penetration or catheter placement, by deriving surrogate trends and/or waveform features from external or physiological signals. Typical approaches follow a “surrogate signal / surrogate waveform” paradigm, leveraging modalities such as ultrasound, ocular assessments, and hemodynamic proxies to generate repeatable trend indicators or morphological features for screening, risk stratification, and longitudinal follow-up.In 2025, global Non-invasive Intracranial Pressure Monitoring Device production reached approximately 12 K Units and price is about 10 K USD/Unit.The average gross profit margin of his product is 50%.
The clinical pace of neurocritical care increasingly favors earlier detection and faster risk stratification, pulling non-invasive ICP monitoring from research exploration into workflow demand. In emergency departments, transport settings, lower-acuity facilities, and resource-limited environments, clinicians want lower-risk signals of ICP change to inform imaging prioritization, monitoring escalation, and pathway selection. Meanwhile, multimodal brain monitoring is strengthening preferences for continuous trends and interpretable waveform features, positioning non-invasive solutions as front-end complements or follow-up adjuncts to invasive pathways and accelerating product evolution toward portability, repeatability, and digital interoperability.The primary constraint is closing the evidence loop between surrogate outputs and clinical decision-making. Many methods are sensitive to anatomical variability, operator dependence, comorbidities, and measurement-window limitations, creating fluctuations in agreement and repeatability. Misinterpreting trend signals as absolute pressures can lead to delayed or unnecessary interventions. Consensus discussions and major reviews commonly frame non-invasive approaches as adjuncts rather than full replacements for invasive reference standards, which raises the bar for regulatory acceptance, guideline uptake, and reimbursement—especially around indications, error characteristics, and interpretability. Downstream priorities are shifting from “can it measure” to “can it be operationalized.” Clinical teams increasingly emphasize bedside usability, repeatability across sessions, sensitivity to dynamic changes, and the ability to work alongside pupillary assessment, ultrasound flow proxies, ocular metrics, and imaging follow-up. Demand is particularly strong for non-invasive tools that support stratified alerts and longitudinal management, including chronic elevated-ICP follow-up use cases where repeated measurements are desirable. As telemedicine and hospital data platforms expand, algorithm-assisted interpretation, quality-control workflows, and traceable data handling are becoming core differentiators. Upstream capability is shaped by sensors and signal chains, attachment/structural components, and algorithms/software as a combined system. Ultrasound and ocular approaches rely on stable probes/imaging modules, optical components, and robust acquisition pipelines. Surface micro-deformation and physiologic waveform-based approaches emphasize high-sensitivity sensors, low-noise front-end electronics, electromagnetic compatibility, and reliable medical-grade adhesives to preserve signal quality during patient movement and routine care. Because many non-invasive products follow reusable-console plus accessory pathways, skin-contact safety, disinfection/durability validation, software lifecycle management, cybersecurity, and standardized data interfaces are increasingly central to supply-chain and quality-system competitiveness.
This report is a detailed and comprehensive analysis for global Non-invasive Intracranial Pressure Monitoring Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-invasive Intracranial Pressure Monitoring Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-invasive Intracranial Pressure Monitoring Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-invasive Intracranial Pressure Monitoring Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-invasive Intracranial Pressure Monitoring Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-invasive Intracranial Pressure Monitoring Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-invasive Intracranial Pressure Monitoring Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, HaiWeiKang, HeadSense Medical, Vittamed, Comen, PrimaNova, TALEND MEDICAL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-invasive Intracranial Pressure Monitoring Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Spot Check
Short Continuous
Serial Followup
Market segment by Form
Handheld Unit
Wearable Patch
Bedside Console
Other
Market segment by Disease Type
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Subarachnoid Hemorrhage
Other
Market segment by Application
Hospital
Clinics
Others
Major players covered
Medtronic
HaiWeiKang
HeadSense Medical
Vittamed
Comen
PrimaNova
TALEND MEDICAL
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-invasive Intracranial Pressure Monitoring Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-invasive Intracranial Pressure Monitoring Device, with price, sales quantity, revenue, and global market share of Non-invasive Intracranial Pressure Monitoring Device from 2021 to 2026.
Chapter 3, the Non-invasive Intracranial Pressure Monitoring Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-invasive Intracranial Pressure Monitoring Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-invasive Intracranial Pressure Monitoring Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-invasive Intracranial Pressure Monitoring Device.
Chapter 14 and 15, to describe Non-invasive Intracranial Pressure Monitoring Device sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Non-invasive Intracranial Pressure Monitoring Device. Industry analysis & Market Report on Non-invasive Intracranial Pressure Monitoring Device is a syndicated market report, published as Global Non-invasive Intracranial Pressure Monitoring Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-invasive Intracranial Pressure Monitoring Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.